| Literature DB >> 24845566 |
Vivi Kasim1, Can Huang2, Jing Zhang2, Huizhen Jia2, Yunxia Wang2, Li Yang3, Makoto Miyagishi4, Shourong Wu5.
Abstract
TAp73, a structural homologue of p53, plays an important role in tumorigenesis. E2F1 had been reported as a transcriptional regulator of TAp73, however, the detailed mechanism remains to be elucidated. Here we reported that MDM2-silencing reduced the activities of the TAp73 promoters and the endogenous TAp73 expression level significantly; while MDM2 overexpression upregulated them. We further revealed that the regulation of TAp73 transcriptional activity occurs as a synergistic effect of MDM2 and E2F1, most probably through their physical interaction in the nuclei. Furthermore, we also suggested that MDM2 might be involved in DNA damage-induced TAp73 transcriptional activity. Finally, we elucidated that MDM2-silencing reduced the proliferation rate of colon carcinoma cells regardless of the p53 status. Our data show a synergistic effect of MDM2 and E2F1 on TAp73 transcriptional activity, suggesting a novel regulation pathway of TAp73.Entities:
Keywords: E2F1; MDM2; Synergistic effect; TAp73
Mesh:
Substances:
Year: 2014 PMID: 24845566 DOI: 10.1016/j.bbrc.2014.05.026
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575